Practical Aspects of Vaccine Development

<p>Section 1: Formulation Development</p> <p>1. Overview of vaccine antigens</p> <p>Katherine Elizabeth Odneal</p> <p>2. Overview of vaccine adjuvants</p> <p>Mansoor M. Amiji, Rushit Lodaya, Sonia Gregory and Derek t. O’Hagan</p> <p>3. Formulation considerations for Live attenuated vaccines</p> <p>Lee Smith</p> <p>4. Subunit based vaccines: Challenges in developing protein based vaccines</p> <p>Charkes Middaugh and Salvador Fernando Ausar</p> <p>5. Formulation development approaches and considerations for protein based vaccines</p> <p>Malte Meppen and Daniela Stranges</p> <p>6. DNA and RNA vaccines</p> <p>Kanwal Gill, Leanne Minall and Aslin Rodriguez Nassif</p> <p>7. Antigen-adjuvant formulation- Key considerations</p> <p>Deep Bhattacharya, Aaron J. Latal, Vamsi Krishna Mudhivarthi and Chris Wiley II</p> <p>8. Suspension Properties and Characterization of Aluminum-Adjuvanted Vaccines</p> <p>Alex Langford</p> <p>Section 2: Process Development </p> <p>9. Effect of shipping stress on suspension vaccines</p> <p>Jianxin Guo and Parag Kolhe</p> <p>10. Developing control strategy for final dose concentration- Case study </p> <p>Deep Bhattacharya and Parag Kolhe</p> <p>11. Lyophilized vaccine development</p> <p>Adora Padilla, Nicole Payton and Rushit Lodaya</p> <p>Section 3: Delivery</p> <p>12. Conventional and non-traditional delivery methods and routes of administration</p> <p>Roberta Antonia Diotti, Giuseppe Andrea Sautto and Valeria Caputo</p>